Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study

Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study

Background. Immunosuppression with calcineurin inhibitors (CNIs) is reportedly associated with risk of renal impairment in liver transplant recipients. It is believed that this can be mitigated by decreasing initial exposure to CNIs or delaying CNI introduction until 3–4 d posttransplantation. The A...

Full description

Bibliographic Details
Main Authors: Styrbjörn Friman, MD, PhD, Giuseppe Tisone, MD, Frederik Nevens, MD, PhD, Frank Lehner, MD, Walter Santaniello, MD, Wolf O. Bechstein, MD, PhD, Sergey V. Zhuvarel, MD, Helena Isoniemi, MD, PhD, Oleg O. Rummo, MD, Jürgen Klempnauer, MD, Swapneel Anaokar, MBBS, MD, Martin Hurst, MBBS, FRCP, Gbenga Kazeem, PhD, Nasrullah Undre, PhD, Pavel Trunečka, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2021-08-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001166

Similar Items

Similar Items